About
Nalu Bio, Inc develops AI-powered drug discovery platform technologies focused on the endocannabinoid system (ECS) to create novel, non-addictive therapeutics targeting inflammatory, immune, metabolic, and neurological diseases.
Explore Nalu Bio, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.